Oxford University Pauses Pediatric Clinical Trial Of AstraZe
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Researchers at Oxford University have paused an ongoing pediatric clinical trial of the coronavirus vaccine it is developing with AstraZeneca. In an official statement, the university said that it is awaiting the results of a safety review from UK regulators, the Medicines and Healthcare products Regulatory Agency (MHRA).

An Oxford spokesperson said "there are no safety concerns concerning the pediatric research, but the trial is paused while they await additional information from MHRA," "which is reviewing possible links between the vaccine and rare blood clots in adults," the spokesperson added. The trial is testing the effectiveness of the vaccine in up to 300 children between the ages of 6 and 17.

Concerns over the blood clotting events in a small number of recipients have dogged the shot in recent weeks and resulted in more than a dozen European countries temporarily suspending the use of the vaccine last month while waiting on the European regulatory agency's recommendations on how to proceed.

The European Medicines Agency (EMA) endorsed the safety of the shot but said it could not rule out a link to the blood clots and would add a warning to the product in order to draw attention to the possibility of such rare side effects. Many European countries are relying heavily on the Oxford-AstraZeneca vaccine, as it is being sold using a nonprofit model and is far cheaper to make than other COVID-19 vaccines.

Source:
https://www.livemint.com/science/health/oxford-halts-dosing-in-trial-of-astrazeneca-covid-vaccine-in-children-teenagers-11617756741977.html
Like
Comment
Share